Edwards Lifesciences (EW)
NYSE:EW
Holding EW?
Track your performance easily

Edwards Lifesciences (EW) Financial Statements

1,812 Followers

Edwards Lifesciences Financial Overview

Edwards Lifesciences's market cap is currently ―. The company's EPS TTM is $6.932; its P/E ratio is 9.55; Edwards Lifesciences is scheduled to report earnings on January 30, 2025, and the estimated EPS forecast is $0.56. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 1.35B$ 1.39B$ 1.60B$ 1.53B$ 1.24B
Gross Profit$ 1.09B$ 1.10B$ 1.21B$ 1.18B$ 992.80M
EBIT$ 378.50M$ 371.10M$ 392.90M$ 314.30M$ 372.50M
EBITDA$ 419.50M$ 418.10M$ 439.10M$ 351.00M$ 416.40M
Net Income Common Stockholders$ 3.07B$ 366.30M$ 351.90M$ 369.90M$ 384.90M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 4.45B$ 1.99B$ 1.70B$ 1.64B$ 1.86B
Total Assets$ 12.97B$ 10.10B$ 9.74B$ 9.36B$ 9.37B
Total Debt$ 706.70M$ 693.00M$ 699.20M$ 694.90M$ 691.10M
Net Debt$ -3.74B$ -1.30B$ -998.40M$ -949.60M$ -1.17B
Total Liabilities$ 3.36B$ 2.59B$ 2.55B$ 2.64B$ 2.64B
Stockholders Equity$ 9.55B$ 7.44B$ 7.12B$ 6.65B$ 6.66B
Cash Flow-
Free Cash Flow$ 294.50M$ 286.10M$ -138.80M$ 35.00M$ 356.20M
Operating Cash Flow$ 351.80M$ 371.50M$ -53.50M$ 136.60M$ 411.50M
Investing Cash Flow$ 2.70B$ 124.80M$ 63.10M$ 14.10M$ 89.00M
Financing Cash Flow$ -976.70M$ -96.60M$ 61.70M$ -413.20M$ -143.30M
Currency in USD

Edwards Lifesciences Earnings and Revenue History

Edwards Lifesciences Debt to Assets

Edwards Lifesciences Cash Flow

Edwards Lifesciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis